Jonathan Alspaugh - President and CFO at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CFO
Stock Symbol
SYRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jonathan Alspaugh since 9/17/2023

Holdings reported by Jonathan Alspaugh for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 19.8M Jun 22, 2023 Direct Common Stock

Transactions reported by Jonathan Alspaugh for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.